French Health Minister Olivier Veran confirmed on Thursday afternoon that Paris had decided to make it possible to give a booster dose to all adults.
The commemorative doses for people aged 18 and over will be available from the end of this week, as added the French Minister of Health.
Elize hopes that with this move he will be able to reduce the new wave of the coronavirus pandemic.
Olivier Veran added during a press conference that the interval between the completion of the full vaccination and the administration of the booster dose will be reduced to five months, instead of the current six.
At the same time, he added that France has several doses of coronavirus vaccine. In particular, he said the country has a stockpile of about 25 million doses of vaccine.
It is worth noting that to date, more than 6 million people in France have already received a commemorative dose.
It is noted that earlier today, the health authorities in France recommended that the booster dose of the Covid-19 vaccine be given as early as the age of 18, 5 months after the full vaccination.
In an opinion issued just six days earlier on Friday, the Supreme Health Authority (HAS) suggested that the booster dose be given from the age of 40, six months after the last injection.
But it decided to reduce those deadlines because the “epidemic resurgence” is “even stronger than expected”, she explained in her new opinion.
“He believes that the worrying epidemic context justifies an acceleration of the vaccination campaign by reducing the deadline between the first full vaccination and the booster dose,” said HAS, whose role is to inspire government policy on these issues.
“It therefore recommends that a booster dose be given as early as 5 months after the first full vaccination and that the booster dose campaign be extended to those 18 years of age and older.”
HAS relies mainly on projections by the Pasteur Institute, which calculate the reduction in the peak of hospitalizations, if the booster dose is given from the age of 18 years.
According to HAS, this reduction is 39% if the booster dose is given 6 months after the last injection, and goes to 50% if the booster dose is given at 5 months.
HAS assures that this strategy is confirmed by “real-life studies conducted in Israel”.
Source From: Capital